Author:
Bozkurt-Güzel Çagla,Gerçeker Ayse Alev
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference29 articles.
1. Miller, M. B. & Gilligan, P. H. Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis. J. Clin. Microbiol. 41, 4009–4015 (2003).
2. Nation, R. L. & Li, J. Colistin in the 21st century. Curr. Opin. Infect. Dis. 22, 535–543 (2009).
3. Craig, W. A. & Gudmundsson, S. in Antibiotics in laboratory medicine. Postantibiotic effect. (ed Lorian, V.) 296–329 Lippincott Williams and Wilkins Co., Baltimore, 1996.
4. Craig, W. A. Pharmacokinetic/pharmacodynamic parameters: the rational for antibacterial dosing in mice and men. Clin. Infect. Dis. 26, 1–10 (1998).
5. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, Eighteenth Informational Supplement, CLSI document M100-S18, CLSI, Wayne, Pennsylvania, USA, 2008.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献